Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Cary J. Claiborne currently holds 350,000 shares of Sucampo Pharmaceuticals, Inc. (SCMP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Cary J. Claiborne has been a net seller of SCMP stock. They have purchased $28.2K and sold $734.6K worth of shares.
Cary J. Claiborne's most recent insider trade was on Dec 5, 2024, when they sold 350,000 shares at $0.00 per share.
Cary J. Claiborne serves as Executive at Sucampo Pharmaceuticals, Inc. (SCMP). They have executed 57 insider transactions totaling $762.7K over their tenure at the company.
Cary J. Claiborne holds the position of Executive at Sucampo Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Cary J. Claiborne has shown a selling trading pattern, with $28.2K in total purchases and $734.6K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Cary J. Claiborne was on Dec 16, 2014, when they sold $553.8K worth of SCMP shares. This transaction involved 42,900 shares at $12.91 per share.
Cary J. Claiborne currently owns 350,000 shares of Sucampo Pharmaceuticals, Inc. (SCMP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Cary J. Claiborne's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Cary J. Claiborne has 57 Form 4 filings on record as an insider at Sucampo Pharmaceuticals, Inc..
Set alerts for Cary J. Claiborne and 40,000+ other insiders.